Skip to main content
Signal8

Hemogenyx Pharmaceuticals Plc (HOPHF)

Hemogenyx Pharmaceuticals Plc is a preclinical-stage biotechnology firm dedicated to discovering, developing, and bringing to market innovative therapies for various blood-related diseases. The company's pipeline includes several promising candidates tailored for the bone marrow/hematopoietic stem cell (BM/HSC) transplant market. These include a CDX bi-specific antibody designed to target relapsed/refractory acute myeloid leukemia (R/R AML), certain forms of acute lymphoblastic leukemia, and myelodysplastic syndrome. This novel approach seeks to condition patients for bone marrow transplants, offering a potential alternative to conventional chemotherapy and/or radiation treatments. Additionally, Hemogenyx is advancing HEMO-CAR-T therapy, which utilizes chimeric antigen receptor T-cells to specifically identify and eradicate human AML-derived cells, demonstrated in both in vitro and in vivo studies. Its portfolio also features Human Postnatal Hematopoietic Endothelial Cells, a unique stem cell therapy intended for BM/HSC transplant applications. Established in 2012, the company maintains its headquarters in London, United Kingdom.

Sector: Biotechnology

Industry: Biotechnology

Hemogenyx Pharmaceuticals Plc logo

Hemogenyx Pharmaceuticals Plc

OTC:HOPHFHealthcare
Mkt Cap-
EV-
Float3.88M
O/S6.9M
Inst Own-
SI<0.1%
Net Cash/Sh-$0.08
Dilution
Financials Summary
Revenue$0
Net Income-$12.88M
Total Assets$5.51M
Free Cash Flow-$4.56M
Debt & Equity
Debt 63%
Equity 37%
Total Debt$2.65M
Total Equity$1.58M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:400Over cap

Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period

  1. 1:400Reverse split
    Dec 13, 2024400 shares → 1
Balance Sheet Details
Assets$5.51M
Liabilities$4M
Accounts Receivable$12K
Accounts Payable$1.27M
Inventory$0
PP&E (Net)$2.38M
Goodwill$0
Intangible Assets$240K
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312015-02-28
Revenue$0$0$0$0$0$0$0$0$0$0$9K$0
YoY Growth------------
Cost of Revenue$1.23M$1.06M$2.23M$3.43M$374K$463K$557K$460K$133K$88K$0$0
Gross Profit-$1.23M-$1.06M-$2.23M-$3.43M-$374K-$463K-$557K-$460K-$133K-$88K$9K$0
Gross Margin----------100.0%-
Research and Development$0$312K$120$643$67$151$37$97$25$0$0$0
Selling, General, and Administrative$2.24M$6.25M$6K$6.46M$1.84M$2.8M$611K$2.15M$541K$544K$233K$8K
Other$5.74M$1.84M$2K-$643$1.72M-$150$1.04M-$398K$545K-$26K$0$0
Total Operating Expenses$7.99M$8.4M$9K$6.46M$3.57M$2.8M$1.65M$1.75M$1.09M$518K$233K$8K
Operating Income (EBIT)-$9.21M-$7.1M-$9K$5.28M-$3.57M-$2.84M-$2.22M-$2.22M-$1.15M-$606K-$224K-$8K
Operating Margin-----------2481.5%-
Interest Expense$303K$448K$304$44$3.43M$44K$41K$2K$14K$16K$0$0
Interest Income$1K$38K$0$14K$24K$4K$19K$6K$19$19$21$0
Other Income (Expense)-$3.68M-$328K-$304$14K-$3.17M$73K$259K$124K-$2.03M-$16K-$15K$0
Income Before Tax (EBT)-$12.89M-$7.42M-$9K-$5.26M-$6.74M-$2.77M-$1.96M-$2.1M-$3.18M-$621K-$239K-$8K
Income Tax Expense$0$0$0$0$0$0-$46K-$58K-$66K$0-$21$0
Net Income-$12.88M-$7.42M-$9K-$5.25M-$6.73M-$2.75M-$1.91M-$2.04M-$3.12M-$1.33M-$239K-$8K
Net Income Margin-----------2642.4%-
Supplementary Data
EPS-2.20-2.13-2.37-1.62-2.64-2.01-1.61-1.72-3.63-1.30-0.01-0.00
Diluted EPS-2.20-2.13-2.37-1.62-2.64-2.01-1.61-1.72-3.63-1.30-0.01-0.00
Weighted Average OS4.44M3.30M2,8222,4491,9341,037901900650362632,86864.90M
EBITDA-$11.81M-$6.25M$845K-$6.45M-$3.4M-$2.7M-$2.1M-$2.15M-$1.1M-$590K$0-$8K
EBITDA Margin------------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312015-02-28
Assets
Current Assets
Cash and Cash Equivalents$2.09M$210K$1.65M$3.34M$9.03M$2.39M$658K$2.33M$2.48M$1.38M$63K$8K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$2.09M$210K$1.65M$3.34M$9.03M$2.39M$658K$2.33M$2.48M$115K$63K$8K
Accounts Receivable$12K$5K$1K$193$2K$7K$40K$85K$87K$217K$0$0
Inventory$0$0$0$0$0$0$0$0$0-$427K$0$0
Other Current Assets$5K$5K$4K$13K$8K$67K$3K-$393-$2K$424K$0$49K
Total Current Assets$2.69M$1.11M$2.86M$3.42M$9.42M$2.53M$732K$2.45M$2.57M$329K$117K$58K
Long-Term Assets
Property, Plant & Equipment Net$2.38M$3.6M$4.37M$5.17M$1.05M$355K$308K$230K$253K$232K$0$0
Goodwill$0$0$38K$0$0$0$0$0$0$0$0$0
Intangible Assets$240K$630K$583K$583K$583K$336K$346K$360K$340K$372K$311K$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$207K$222K$203K$186K$188K$295K$0$0$0-$995$0$0
Total Long-Term Assets$2.83M$4.45M$5.2M$5.94M$1.82M$986K$654K$590K$593K$602K$311K$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$5.51M$5.56M$8.06M$9.36M$11.25M$3.52M$1.39M$3.04M$3.16M$1.38M$428K$58K
Liabilities
Current Liabilities
Accounts Payable$1.27M$902K$398K$494K$390K$149K$81K$121K$10K$22K$7K$0
Short-Term Debt$584K$559K$0$0$0$2.08M$0$0$0$51K$15K$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities-$502K-$491K$0$0$0$0$0$0$0$0$0$0
Total Current Liabilities$1.94M$1.53M$861K$988K$466K$2.35M$240K$221K$348K$73K$21K$0
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$1.51M$1.55M$0$348K$304K$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$2.06M$2.9M$3.53M$4.09M$0$13K$1.61M$1.55M$0$348K$304K$0
Other Liabilities$0$0$0$0$0$0$0$0$0-$348K$0$0
Total Liabilities$4M$4.43M$4.39M$5.08M$466K$2.36M$1.85M$1.77M$348K$190K$326K$0
Stockholders' Equity
Preferred Stock$0$0$0$78K$0$0$0$0$0$0$0$0
Common Stock$18.53M$46K$15.52M$12.93M$12.93M$5.72M$4.77M$4.75M$4.75M$883K$341K$66K
Retained Earnings-$59.26M-$38.83M-$31.42M-$22.59M-$17.34M-$10.61M-$7.86M-$6M-$3.97M-$801K-$239K-$8K
Comprehensive Income & Other$3.72M$11.74M-$6.69M-$78K-$6.97M-$7.13M-$7.53M-$7.17M-$7.66M$30K$0$0
Other Stockholders' Equity$42.31M$39.97M$19.62M$13.98M$15.22M$6.06M$2.63M$2.52M$2.03M$1.11M-$1$0
Total Equity$1.58M$1.18M$3.72M$4.32M$10.81M$1.18M-$457K$1.27M$2.81M$1.19M$103K$58K
Minority Interest-$67K-$58K-$50K-$42K-$32K-$20K-$3K$0$0$0$0$0
Total Liabilities and Equity$5.58M$5.62M$8.11M$9.4M$11.28M$3.54M$1.39M$3.04M$3.16M$1.38M$428K$58K
Supplementary Data
Total Debt$2.65M$3.46M$3.89M$4.52M$13K$2.15M$1.66M$1.55M$0$397K$319K$0
Net Debt$551K$3.25M$2.24M$1.17M-$9.02M-$243K$1M-$778K-$2.48M-$983K$256K-$8K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312015-02-28
Operating Activities
Net Income-$12.89M-$7.42M-$8.84M-$5.26M-$6.74M-$2.77M-$1.92M-$2.04M-$3.12M-$621K-$239K-$8K
Depreciation & Amortization$777K$844K$852K$742K$167K$141K$125K$68K$44K$16K$224K$0
Deferred Income Tax$0$0$0$5K-$24K-$194K$27K-$65K$0$0$0$0
Stock-Based Compensation$83K$454K$321K$23K$202K$479K$162K$408K$47K$106K$73K$0
Changes in Working Capital:
  Accounts Receivable-$7K-$3K$6K-$3K-$260K-$28K$21K-$25K$114K-$215K-$55K$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0$0$0-$36K$393K-$47K$0$0$0$0$0$0
  Other Working Capital$1.27M$342K-$1.11M$359K$393K$822-$24K-$130K-$2K$0$0$0
Total Working Capital Change$1.26M$338K-$1.1M$320K$134K-$75K-$2K-$156K$112K-$215K-$55K$0
Other Non-Cash Items$6.22M$325K$707K$330K$2.8M$40K$23K-$3K$2.32M$2K$102K$0
Net Cash from Operating-$4.55M-$5.46M-$8.06M-$3.84M-$3.47M-$2.37M-$1.58M-$1.79M-$598K-$713K$105K-$8K
Investing Activities
Capital Expenditures-$5K-$18K-$155K-$566K-$1.08M-$228K-$16K-$32K-$85K-$249K$0$0
Acquisitions$0$0$0$0$0$0$0$0$1.45M$0$0$0
Purchases of Investments$0$0$0-$3K-$183K$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities-$4K$15K$113K$14K$24K$4K$19K$6K-$368$288-$311K$0
Net Cash from Investing-$9K-$2K-$42K-$555K-$1.24M-$224K$3K-$27K$1.36M-$249K-$311K$0
Financing Activities
Debt Repaid-$838K---$11.64M-$4.76M--$1.55M$204K---
Common Stock Issuance$7.29M$6.13M$6.72M$0$15.84M$46K$0$7K$2.64M$996K$0$16K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$835K-$1.23M-$843K-$145K-$76K-$572K-$52K$0-$830K$0$268K$0
Net Cash from Financing$6.45M$4.06M$5.87M-$145K$11.59M$4.24M-$52K$1.56M$1.61M$996K$268K$16K
Forex Effect-$10K-$32K$532K-$1.16M-$241K$92K-$35K$103K-$11K$18K$0$0
Net Change in Cash$1.88M-$1.44M-$1.7M-$5.69M$6.64M$1.73M-$1.67M-$151K$2.36M$53K$63K$8K
Supplementary Data
Operating Cash Flow-$4.55M-$5.46M-$8.06M-$3.84M-$3.47M-$2.37M-$1.58M-$1.79M-$598K-$367K$105K-$8K
Capital Expenditure-$5K-$18K-$155K-$566K-$1.08M-$228K-$16K-$32K-$85K-$249K$0$0
Free Cash Flow-$4.56M-$5.48M-$8.21M-$4.41M-$4.55M-$2.6M-$1.6M-$1.82M-$683K-$616K$105K-$8K
Cash at Beginning$210K$1.65M$3.34M$9.03M$2.39M$658K$2.33M$2.48M$115K$1.75M$89$0
Cash at End$2.09M$210K$1.65M$3.34M$9.03M$2.39M$658K$2.33M$2.48M$1.38M$63K$8K